Cargando…
Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant
Herpes zoster (HZ) is one of two distinct syndromes caused by Varicella-zoster virus (VZV). A primary infection with VZV causes varicella in susceptible young children. After resolution of the primary infection, VZV establishes a lifelong latency within the cranial or dorsal root ganglia. With incre...
Autores principales: | Li, Junli, Fu, Lili, Yang, Yang, Wang, Guozhi, Zhao, Aihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029549/ https://www.ncbi.nlm.nih.gov/pubmed/35455278 http://dx.doi.org/10.3390/vaccines10040529 |
Ejemplares similares
-
Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus
por: Li, Junli, et al.
Publicado: (2022) -
Comparison of the Immune Responses to Different Formulations of BC02-Adjuvanted HPV Types 16 and 18 Bivalent Vaccines in Mice
por: Li, Junli, et al.
Publicado: (2023) -
Processing of virus-specific glycoproteins of varicella zoster virus
por: Namazue, Junko, et al.
Publicado: (1985) -
Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021) -
Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
por: Schwarz, Tino F., et al.
Publicado: (2018)